[
  {
    "filename": "ALD_GvHD provisional patent.pdf",
    "page_number": 6,
    "has_header": false,
    "header": null,
    "section": "detailed description",
    "text": "iS\n\n20)\n\nWO 2022/221616 PCT/US2022/024946\n\nimmunized hens was used as the control Te. Specific aciivity is represented by the antibody\n\nreactivity and titer.\n\nFigure 4 shows the inhibitory effects of ..."
  },
  {
    "filename": "ALD_GvHD provisional patent.pdf",
    "page_number": 7,
    "has_header": false,
    "header": null,
    "section": "detailed description",
    "text": "WO 2022/221616 PCT/US2022/024946\n\nA \"hyperimmune state” refers to an clevated immune response in an ogg producing\n\nOm cS\n\nanimal that has been hyperimmunized.\n\nThe term \"egg\" as used herein refers to ..."
  },
  {
    "filename": "ALD_GvHD provisional patent.pdf",
    "page_number": 8,
    "has_header": false,
    "header": null,
    "section": "detailed description",
    "text": "1\n\nI\n\n9\n\nMm\n\n0\n\n5\n\n20)\n\ntat\n\nWO 2022/221616 PCT/US2022/024946\n\nio a particular antigen are levels of the antibody in excess af those found in eggs of egg-\n\nOO\n\nprodacing animals that are not hyperimmu..."
  },
  {
    "filename": "ALD_GvHD provisional patent.pdf",
    "page_number": 9,
    "has_header": false,
    "header": null,
    "section": "detailed description",
    "text": "20\n\nWO 2022/221616 PCT/US2022/024946\n\nsexual dysfunction; aicahol-induced sleep disorder; and alcohol-related disarder not otherwise\n\nspecified (NOS).\n\nThe term “alcohol abuser”, as used herein, refer..."
  },
  {
    "filename": "ALD_GvHD provisional patent.pdf",
    "page_number": 10,
    "has_header": false,
    "header": null,
    "section": "detailed description",
    "text": "WO 2022/221616 PCT/US2022/024946\n\nand Interleukin 8), oxidative stress, lipid peroxidation, and acetaldehyde toxicity. These factors\ncause inflammation, apoptosis and eventually fibrosis of liver cell..."
  },
  {
    "filename": "ALD_GvHD provisional patent.pdf",
    "page_number": 11,
    "has_header": false,
    "header": null,
    "section": "detailed description",
    "text": "nN\nal\n\nWO 2022/221616 PCT/US2022/024946\n\nChronic liver disease cue ta aicohol-use disorder contributes markedly to the global\nburden of disease and mortality. The most severe form of alcohol-related l..."
  },
  {
    "filename": "ALD_GvHD provisional patent.pdf",
    "page_number": 12,
    "has_header": false,
    "header": null,
    "section": "detailed description",
    "text": "WO 2022/221616 PCT/US2022/024946\n\ndays. The appearance of moderate to severe cases of chronic GVHD adversely influences long-\n\nterm survival.\n\nAcute GVHD (aGVHD) affects the skin, liver, and gastroint..."
  },
  {
    "filename": "ALD_GvHD provisional patent.pdf",
    "page_number": 13,
    "has_header": false,
    "header": null,
    "section": "detailed description",
    "text": "20\n\nWO 2022/221616 PCT/US2022/024946\n\ncomponent, Class TP antibiotics, Antibiotics are compiex palycyclic antimicrabial peptides,\nwhich are ribosomally synthesized by Gram-positive bacteria and are ch..."
  },
  {
    "filename": "ALD_GvHD provisional patent.pdf",
    "page_number": 14,
    "has_header": false,
    "header": null,
    "section": "detailed description",
    "text": "bo\noS\n\nBo\noa\n\nSed\nrom]\n\nWO 2022/221616 PCT/US2022/024946\n\nin certain aspects, the present disclasure relates to. a method of preparing a\nhyperimmunized egy product comprising: i) hyperimmunizing an eg..."
  },
  {
    "filename": "ALD_GvHD provisional patent.pdf",
    "page_number": 15,
    "has_header": false,
    "header": null,
    "section": "detailed description",
    "text": "RD\nCoe)\n\nWO 2022/221616 PCT/US2022/024946\n\nwhich comes from an avian which has been brought to a specific state of immunization by means\nof for example, periodic booster admimstrations of antigens. Hy..."
  },
  {
    "filename": "ALD_GvHD provisional patent.pdf",
    "page_number": 16,
    "has_header": false,
    "header": null,
    "section": "detailed description",
    "text": "10\n\n20\n\nWO 2022/221616 PCT/US2022/024946\n\nmixtures of antigens. The dosage of the booster may be 10%, 20%, 30%, 40%, 50%, 60%, 70%,\n80%, 90% or 100% of the dosage necessary to produce primary immuniza..."
  },
  {
    "filename": "ALD_GvHD provisional patent.pdf",
    "page_number": 17,
    "has_header": false,
    "header": null,
    "section": "detailed description",
    "text": "bBo\n\nb>\nmn\n\nWO 2022/221616 PCT/US2022/024946\n\nhyperimmunized with Knterecocens faecium, Enterococcus faecalis and isolated Hnteracoccus\njaecatis cytolysin toxin. In some embodiments, the egg-producing..."
  },
  {
    "filename": "ALD_GvHD provisional patent.pdf",
    "page_number": 18,
    "has_header": false,
    "header": null,
    "section": "detailed description",
    "text": "tat\n\nMm\n\nWO 2022/221616 PCT/US2022/024946\n\nmethods of administration that can be used inchade intravenous injection, intrapentoneal\n\ninjection, intradermal, rectal suppository, aerosol or oral adminis..."
  },
  {
    "filename": "ALD_GvHD provisional patent.pdf",
    "page_number": 19,
    "has_header": false,
    "header": null,
    "section": "detailed description",
    "text": "nN\nal\n\nWO 2022/221616 PCT/US2022/024946\n\nTn same embodiments, the hyper: mmunized egg product comprises antibodies to\nEnierococcus fuecium. Tn certain embodiments, the hypenmmunized egg product compri..."
  },
  {
    "filename": "ALD_GvHD provisional patent.pdf",
    "page_number": 20,
    "has_header": false,
    "header": null,
    "section": "detailed description",
    "text": "ho\na\n\nWO 2022/221616 PCT/US2022/024946\n\n300%, 400% or 500% more antibody (e.g. Is¥ antibody) specitic to Materococeus faecatis\n\nrelative to a control egg or control egg product obtained from an egg-pr..."
  },
  {
    "filename": "ALD_GvHD provisional patent.pdf",
    "page_number": 21,
    "has_header": false,
    "header": null,
    "section": "detailed description",
    "text": "10\n\ni\naa\n\nho\na\n\nWO 2022/221616 PCT/US2022/024946\n\nmore antibody to Materococcus faecalis, and at least 10%, 20%, 30%, 40%, 50%, 100%, 200%,\n300%, 400% or 300% more antibody to Enterococcus faecalis cy..."
  },
  {
    "filename": "ALD_GvHD provisional patent.pdf",
    "page_number": 22,
    "has_header": false,
    "header": null,
    "section": "detailed description",
    "text": "10\n\ni\nca\n\nbho\n\naT\n\nWO 2022/221616 PCT/US2022/024946\n\nwith antigens (e.g, an Menerococcus jaecalis antigen, isoiated Materococcus faecalis cytolysin\ntoxin, or an Enflerococcus faeciom antigen) at 1Oug/..."
  },
  {
    "filename": "ALD_GvHD provisional patent.pdf",
    "page_number": 23,
    "has_header": false,
    "header": null,
    "section": "detailed description",
    "text": "nN\n\nas\n\nWO 2022/221616 PCT/US2022/024946\n\nand the egg white weighing approximately 40 grains, In same embodiments, 3 grams of ege yolk\ncontains approximately 20-30 milligrams of total IgY, such that a..."
  },
  {
    "filename": "ALD_GvHD provisional patent.pdf",
    "page_number": 24,
    "has_header": false,
    "header": null,
    "section": "detailed description",
    "text": "nN\n\nas\n\n0\n\nWO 2022/221616 PCT/US2022/024946\n\nbe mixed with an agent such as silicon or silicon derivatives that improves flow properties The\ndried hyperimmunized egg product may comprise a desiccant. ..."
  },
  {
    "filename": "ALD_GvHD provisional patent.pdf",
    "page_number": 25,
    "has_header": false,
    "header": null,
    "section": "detailed description",
    "text": "RD\nCoe)\n\nWO 2022/221616 PCT/US2022/024946\n\nembodiments, larger microparticles or particles may be used. Far example the microparticies\nmay have a diameter ranging from 10 microns to 1000 microns. In c..."
  },
  {
    "filename": "ALD_GvHD provisional patent.pdf",
    "page_number": 26,
    "has_header": false,
    "header": null,
    "section": "detailed description",
    "text": "i\n\nRD\nCoe)\n\n0\n\n0\n\nWO 2022/221616 PCT/US2022/024946\n\nhyperimmunized egg product. An increase in the proportion of Hnterocnecis spp. in patients\nwith alcoholic liver disease (e.g. alcoholic hepatitis} r..."
  },
  {
    "filename": "ALD_GvHD provisional patent.pdf",
    "page_number": 27,
    "has_header": false,
    "header": null,
    "section": "detailed description",
    "text": "Mm\n\ntat\n\nWO 2022/221616 PCT/US2022/024946\n\ntransplant, a bone marrow transplant, or an allogeneic hematapotetic cell transplant. In some\nembodiments, the subject has acute GVHD. In some embodiments, t..."
  },
  {
    "filename": "ALD_GvHD provisional patent.pdf",
    "page_number": 28,
    "has_header": false,
    "header": null,
    "section": "detailed description",
    "text": "ho\na\n\nWO 2022/221616 PCT/US2022/024946\n\nTn certain embodiments, whole eggs are divided into separate fractions such as egg yalks\nand egy whites. For example, itis generally known in the art that Ig ¥ ..."
  },
  {
    "filename": "ALD_GvHD provisional patent.pdf",
    "page_number": 29,
    "has_header": false,
    "header": null,
    "section": "detailed description",
    "text": "ha\n\nray\n\nWO 2022/221616 PCT/US2022/024946\n\nconcentrated hy methods well-known in the art, from several hundred eggs. Tn certain\nembodiments, the effective amount of the hyperimmunized egg procuct admi..."
  },
  {
    "filename": "ALD_GvHD provisional patent.pdf",
    "page_number": 30,
    "has_header": false,
    "header": null,
    "section": "detailed description",
    "text": "10\n\nbho\n\naa\n\nWO 2022/221616 PCT/US2022/024946\n\nMethods\n\nPreparation of Hyperimmune Ege Powder\n\nTwo (2) mL of primary culture of Eaterococcus faecafis was initiated from glycerol stocks. A large\nbatch ..."
  },
  {
    "filename": "ALD_GvHD provisional patent.pdf",
    "page_number": 31,
    "has_header": false,
    "header": null,
    "section": "detailed description",
    "text": "10\n\ni\naa\n\nWO 2022/221616 PCT/US2022/024946\n\nNaCl at pH 4 and allowed to precipitate for 2h. IgY was separated from the precipitate by\ncentrifugation and excess salt was removed by dialysis in PBS. Tot..."
  },
  {
    "filename": "ALD_GvHD provisional patent.pdf",
    "page_number": 32,
    "has_header": false,
    "header": null,
    "section": "detailed description",
    "text": "15\n\nbho\naT\n\nWO 2022/221616 PCT/US2022/024946\n\nEvaluation of Target Specific Antibody Titer\n\nSpecific activity of Ig¥ antibody against F. faecalis and cytolysin antigens was measured by indirect\nELISA...."
  },
  {
    "filename": "ALD_GvHD provisional patent.pdf",
    "page_number": 33,
    "has_header": false,
    "header": null,
    "section": "detailed description",
    "text": "WO 2022/221616 PCT/US2022/024946\n\n511. Periodically the mice were evaluated for senim ALT, liver pathology and other parameters such\n\nony\n\nas weight gain, liver weight, and feed intake.\n\nMale and fema..."
  },
  {
    "filename": "ALD_GvHD provisional patent.pdf",
    "page_number": 34,
    "has_header": false,
    "header": null,
    "section": "detailed description",
    "text": "20\n\nWO 2022/221616 PCT/US2022/024946\n\nSerum levels of alanine aminotransferase (ALT, a test for liver damage) were measured using an\nInfimty ALT kit (Thermo Scientilic). Hepatic triglyceride levels we..."
  }
]